Interesting, market cap was 195M in 2015, to 5B in
Post# of 144782
Eli Lilly (NYSE:LLY) has completed its acquisition of 26,043,820 common shares of Loxo Oncology (NASDAQ:LOXO) at $235 per share for a total of ~$6.12B, representing an 84.6% stake. Lilly will acquire the remaining non-tendered shares through a second-step merger.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)